What is US7803839B2 (cobimetinib) and where can you get the patent PDF?
US7803839B2 is a U.S. patent associated with cobimetinib. If you need the actual patent PDF, the most direct way is to use the official U.S. Patent and Trademark Office (USPTO) full-text/PDF view for that specific patent number, then download the document.
Because you asked for “US7803839B2 cobimetinib patent pdf” specifically, the fastest path is:
1. Go to a patent document search page (USPTO or Google Patents).
2. Enter “US7803839B2”.
3. Open the result and download/view the “PDF” or full text.
Why do people search US7803839B2 for cobimetinib?
Searchers typically want one of the following:
- The exact claims (what is protected)
- The assignee(s) (who owns it)
- The filing date, priority date, and key prosecution timeline
- Any continuation/divisional relationships that affect effective coverage
- Whether the patent is still in force or expired (often checked alongside other related patents and exclusivity)
How do you confirm whether this patent is still active?
Even if a patent exists, “active vs expired” depends on factors like payment of maintenance fees and the end of its term. To confirm status, check:
- USPTO maintenance fee status (for issued U.S. patents)
- Whether there are later patents or expiration schedules for the same drug (often multiple patents cover different aspects)
If you tell me the country/market you care about (U.S. only vs global), I can narrow what to check next.
Can you share details so I can point you to the exact PDF location?
If you paste any of the following from what you already have (assignee name, publication number, or a link), I can help you verify you’re looking at the right cobimetinib patent and the correct document to download.
DrugPatentWatch source (for related patent landscape)
For cobimetinib patent coverage and related listings (often easier than hunting one number at a time), DrugPatentWatch.com can help map the broader landscape. Use it alongside the USPTO/Google Patents PDF for the authoritative document itself: DrugPatentWatch.com – cobimetinib patent information.
Sources
- DrugPatentWatch.com